Targeting immunometabolism as an anti-inflammatory strategy

Area of Science:

• Immunometabolism
• Cellular Metabolism
• Inflammation Biology

Background:

• Metabolic cellular processes are crucial for generating energy and biosynthetic precursors.
• Metabolic reprogramming of immune cells is fundamental for both inflammatory and anti-inflammatory responses.
• Existing anti-inflammatory therapies like DMF, Metformin, Methotrexate, and Rapamycin impact cellular metabolism.

Purpose of the Study:

• To review recent advancements in targeting immunometabolism for anti-inflammatory strategies.
• To explore the potential of targeting specific metabolic events to control inflammation.
• To highlight glycolysis and the TCA cycle as key areas for novel therapeutic development.

Main Methods:

• Literature review of immunometabolism and anti-inflammatory therapies.
• Analysis of how metabolic pathways influence immune cell function.
• Discussion of metabolic intermediates and enzymes as potential therapeutic targets.

Main Results:

• Metabolic reprogramming is essential for immune cell function in inflammation and resolution.
• Several established anti-inflammatory drugs exert their effects by modulating metabolism.
• Emerging evidence supports targeting specific metabolic pathways to limit inflammation.

Conclusions:

• Targeting immunometabolism represents a promising frontier for novel anti-inflammatory therapeutics.
• Metabolic intermediates and enzymes, particularly within glycolysis and the TCA cycle, offer potential therapeutic targets.
• Further research into immunometabolism could lead to innovative treatments for inflammatory diseases.